MYCN amplification and MYC expression have been shown to correlate with a neuroblastoma tumor microenvironment low in infiltrating immune cells and low cellular immunity, suggesting its role in suppressing immunogenicity [61,62,63]. The gene discussed is MYCN; the disease is neoplasm.